As of March 23, 2026, Spruce Biosciences's top three insider holders are Ralph William Iii Charlton (Chief Medical Officer, 161.34K shares), Javier B. Szwarcberg (Chief Executive Officer, 19.00K shares), Douglas Kirk Ways (Interim Chief Medical Officer, 1.25K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ralph William Iii Charlton | Chief Medical Officer | 161,339 | 0 | 20 Dec, 2024 |
| Javier B. Szwarcberg | Chief Executive Officer | 19,004 | 0 | 05 Jan, 2026 |
| Douglas Kirk Ways | Interim Chief Medical Officer | 1,250 | 0 | 21 Jan, 2026 |
| Healthcare Partners Llc Parkman | 0 | 1,050 | 15 Oct, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Corwin Dale Hooks | Restricted Stock Units | A | 11,000 | $0.00 | 11,000 | D | A |
| 11 Dec, 2025 | Douglas Kirk Ways | Common Stock | A | 1,250 | $0.00 | 1,250 | D | M |
| 11 Dec, 2025 | Douglas Kirk Ways | Restricted Stock Units | A | 5,000 | $0.00 | 5,000 | D | A |
| 11 Dec, 2025 | Douglas Kirk Ways | Restricted Stock Units | D | 1,250 | $0.00 | 3,750 | D | M |
| 11 Dec, 2025 | Douglas Kirk Ways | Stock Option (Right to Buy) | A | 266 | - | 266 | D | A |
| 11 Dec, 2025 | Douglas Kirk Ways | Stock Option (Right to Buy) | D | 266 | - | 0 | D | D |
| 11 Dec, 2025 | Douglas Kirk Ways | Stock Option (Right to Buy) | A | 400 | - | 400 | D | A |
| 11 Dec, 2025 | Douglas Kirk Ways | Stock Option (Right to Buy) | D | 400 | - | 0 | D | D |
| 31 Dec, 2025 | Javier B. Szwarcberg | Common Stock | A | 4,690 | $4.53 | 19,004 | D | A |
| 15 Dec, 2025 | Javier B. Szwarcberg | Common Stock | A | 1,480 | $0.00 | 14,478 | D | M |
| 15 Dec, 2025 | Javier B. Szwarcberg | Common Stock | D | 752 | $80.67 | 13,726 | D | F |
| 15 Dec, 2025 | Javier B. Szwarcberg | Common Stock | A | 1,196 | $0.00 | 14,922 | D | M |
| 15 Dec, 2025 | Javier B. Szwarcberg | Common Stock | D | 608 | $80.67 | 14,314 | D | F |
| 11 Dec, 2025 | Javier B. Szwarcberg | Employee Stock Option (right to buy) | A | 1,666 | - | 1,666 | D | A |
| 11 Dec, 2025 | Javier B. Szwarcberg | Employee Stock Option (right to buy) | D | 1,666 | - | 0 | D | D |
| 15 Dec, 2025 | Javier B. Szwarcberg | Restricted Stock Units | D | 1,480 | $0.00 | 1,480 | D | M |
| 15 Dec, 2025 | Javier B. Szwarcberg | Restricted Stock Units | D | 1,196 | $0.00 | 2,392 | D | M |
| 11 Dec, 2025 | Keli Walbert | Stock Option (Right to Buy) | A | 3,400 | $0.00 | 3,400 | D | A |
| 11 Dec, 2025 | Javier B. Szwarcberg | Employee Stock Option (right to buy) | A | 10,000 | - | 10,000 | D | A |
| 11 Dec, 2025 | Camilla V Simpson | Stock Option (Right to Buy) | A | 173 | - | 173 | D | A |